{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:49:03Z","timestamp":1792165743795,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Nanjing University of Traditional Chinese Medicine","award":["XZR2024095"],"award-info":[{"award-number":["XZR2024095"]}]},{"name":"Key Research and Development Plan for Social Development in Zhenjiang City","award":["SH2024027"],"award-info":[{"award-number":["SH2024027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-026-00356-y","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:16:22Z","timestamp":1784632582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Huangjing Jiangzhi Granules Ameliorate Nonalcoholic Fatty Liver Disease by Activating the FOXA1-DERL1 Regulatory Axis to Suppress Lipid Accumulation, Endoplasmic Reticulum Stress, and Apoptosis"],"prefix":"10.1186","volume":"28","author":[{"given":"Dongyu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haina","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"10290","key":"356_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet (London England). 2021;397(10290):2212\u201324. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3. Epub 20210421.","journal-title":"Lancet (London England)"},{"issue":"1","key":"356_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1. Epub 20220314.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"356_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1515\/jtim-2026-0007","volume":"14","author":"S He","year":"2026","unstructured":"He S, Wang K, Li B, Fang W, Wei X, Yao F, et al. Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model. J Transl Int Med. 2026;14(1):134\u201349. https:\/\/doi.org\/10.1515\/jtim-2026-0007. Epub 2026\/02\/23.","journal-title":"J Transl Int Med"},{"issue":"8","key":"356_CR4","doi-asserted-by":"publisher","first-page":"e55192","DOI":"10.15252\/embr.202255192","volume":"23","author":"K Mochida","year":"2022","unstructured":"Mochida K, Nakatogawa H. ER-phagy: selective autophagy of the endoplasmic reticulum. EMBO Rep. 2022;23(8):e55192. Epub 20220627. doi: 10.15252\/embr.202255192. PubMed PMID: 35758175; PubMed Central PMCID: PMCPMC9346472.","journal-title":"EMBO Rep"},{"key":"356_CR5","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.plipres.2022.101198","volume":"89","author":"C Celik","year":"2023","unstructured":"Celik C, Lee SYT, Yap WS, Thibault G. Endoplasmic reticulum stress and lipids in health and diseases. Prog Lipid Res. 2023;89:101198. https:\/\/doi.org\/10.1016\/j.plipres.2022.101198. Epub 20221113.","journal-title":"Prog Lipid Res"},{"key":"356_CR6","doi-asserted-by":"publisher","first-page":"116972","DOI":"10.1016\/j.ecoenv.2024.116972","volume":"284","author":"M Tian","year":"2024","unstructured":"Tian M, Cao H, Gao H, Zhu L, Wu Y, Li G. Rotenone-induced cell apoptosis via endoplasmic reticulum stress and PERK-eIF2\u03b1-CHOP signalling pathways in TM3 cells. Ecotoxicol Environ Saf. 2024;284:116972. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116972. Epub 20240903.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"356_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/15548627.2022.2103992","volume":"19","author":"TM Zhang","year":"2023","unstructured":"Zhang TM, Liao L, Yang SY, Huang MY, Zhang YL, Deng L, et al. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Autophagy. 2023;19(3):805\u201321. PubMed PMID: 35920704; PubMed Central PMCID: PMCPMC9980475.","journal-title":"Autophagy"},{"issue":"1","key":"356_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12935-024-03395-1","volume":"24","author":"Y Bai","year":"2024","unstructured":"Bai Y, Zhang Z, Bi J, Tang Q, Jiang K, Yao C, et al. miR-181c-5p\/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT. Cancer Cell Int. 2024;24(1):204. https:\/\/doi.org\/10.1186\/s12935-024-03395-1. Epub 20240610.","journal-title":"Cancer Cell Int"},{"key":"356_CR9","doi-asserted-by":"publisher","first-page":"991083","DOI":"10.3389\/fphar.2022.991083","volume":"13","author":"PH Murudkar","year":"2022","unstructured":"Murudkar PH, Tambe MS, Chandrasekar SB, Boddeda B, Pawar AT. Common Ayurvedic, Chinese traditional and Unani antidiabetic formulations- a review. Front Pharmacol. 2022;13:991083. https:\/\/doi.org\/10.3389\/fphar.2022.991083. Epub 20221012.","journal-title":"Front Pharmacol"},{"issue":"1","key":"356_CR10","doi-asserted-by":"publisher","first-page":"e30014","DOI":"10.1371\/journal.pone.0030014","volume":"7","author":"M Moya","year":"2012","unstructured":"Moya M, Benet M, Guzm\u00e1n C, Tolosa L, Garc\u00eda-Monz\u00f3n C, Pareja E, et al. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. PLoS ONE. 2012;7(1):e30014. https:\/\/doi.org\/10.1371\/journal.pone.0030014. Epub 2012\/01\/13.","journal-title":"PLoS ONE"},{"issue":"4","key":"356_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbalip.2012.12.014","volume":"1831","author":"C Guzm\u00e1n","year":"2013","unstructured":"Guzm\u00e1n C, Benet M, Pisonero-Vaquero S, Moya M, Garc\u00eda-Mediavilla MV, Mart\u00ednez-Chantar ML, et al. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR\u03b1; and repressed by C\/EBP\u03b1: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim Biophys Acta. 2013;1831(4):803\u201318. https:\/\/doi.org\/10.1016\/j.bbalip.2012.12.014. Epub 2013\/01\/16.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"356_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41419-024-07054-1","volume":"15","author":"D Zou","year":"2024","unstructured":"Zou D, Liao J, Xiao M, Liu L, Dai D, Xu M. Impaired SUMOylation of FoxA1 promotes nonalcoholic fatty liver disease through down-regulation of Sirt6. Cell Death Dis. 2024;15(9):674. https:\/\/doi.org\/10.1038\/s41419-024-07054-1. Epub 2024\/09\/15.","journal-title":"Cell Death Dis"},{"key":"356_CR13","doi-asserted-by":"publisher","first-page":"155292","DOI":"10.1016\/j.metabol.2022.155292","volume":"136","author":"X Liu","year":"2022","unstructured":"Liu X, Hou S, Xiang R, Hu C, Chen Z, Li N, et al. Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis. Metabolism. 2022;136:155292. https:\/\/doi.org\/10.1016\/j.metabol.2022.155292. Epub 2022\/08\/23.","journal-title":"Metabolism"},{"key":"356_CR14","doi-asserted-by":"publisher","unstructured":"Yang L, Ma Q, Chen J, Kong X, Yu X, Wang W. Foxa2 attenuates steatosis and inhibits the NF-\u03baB\/IKK signaling pathway in nonalcoholic fatty liver disease. PeerJ. 2023;11:e16466. https:\/\/doi.org\/10.7717\/peerj.16466. Epub 2023\/12\/12. PubMed PMID: 38084145; PubMed Central PMCID: PMCPMC10710773.","DOI":"10.7717\/peerj.16466"},{"issue":"1","key":"356_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","volume":"75","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou B, Meng M, Zhao W, Wang D, Yuan Y, et al. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol. 2021;75(1):150\u201362. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.042. Epub 2021\/02\/07.","journal-title":"J Hepatol"},{"key":"356_CR16","doi-asserted-by":"publisher","first-page":"177509","DOI":"10.1016\/j.ejphar.2025.177509","volume":"998","author":"G Alotaibi","year":"2025","unstructured":"Alotaibi G, Alkhammash A. Pharmacological landscape of endoplasmic reticulum stress: Uncovering therapeutic avenues for metabolic diseases. Eur J Pharmacol. 2025;998:177509. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177509. Epub 20250313.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"356_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54(4):795\u2013809. Epub 20101113. doi: 10.1016\/j.jhep.2010.11.005. PubMed PMID: 21145844; PubMed Central PMCID: PMCPMC3375108.","journal-title":"J Hepatol"},{"issue":"3","key":"356_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59(3):583\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2013.03. Epub 20130406.","journal-title":"J Hepatol"},{"key":"356_CR19","doi-asserted-by":"publisher","first-page":"107467","DOI":"10.1016\/j.aquatox.2025.107467","volume":"286","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Zhu J, Zheng X, Luo T, Lv S. Derlin-1 modulated endoplasmic reticulum stress and apoptosis in Acipenser schrenckii hepatocytes under titanium dioxide nanoparticle exposure. Aquat Toxicol. 2025;286:107467. https:\/\/doi.org\/10.1016\/j.aquatox.2025.107467. Epub 20250619.","journal-title":"Aquat Toxicol"},{"issue":"1","key":"356_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s42003-025-08880-5","volume":"8","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yao D, Rao B, Xia Y, Li W, Li S, et al. Cryo-EM structure of the human Derlin-1\/p97 complex reveals a hexameric channel in ERAD. Commun Biol. 2025;8(1):1481. https:\/\/doi.org\/10.1038\/s42003-025-08880-5. Epub 20251017.","journal-title":"Commun Biol"},{"key":"356_CR21","doi-asserted-by":"publisher","first-page":"121877","DOI":"10.1016\/j.lfs.2023.121877","volume":"328","author":"G Cao","year":"2023","unstructured":"Cao G, Lin M, Gu W, Su Z, Duan Y, Song W, et al. The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts. Life Sci. 2023;328:121877. https:\/\/doi.org\/10.1016\/j.lfs.2023.121877. Epub 20230622.","journal-title":"Life Sci"},{"issue":"19\u201320","key":"356_CR22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00018-006-6095-6","volume":"63","author":"JR Friedman","year":"2006","unstructured":"Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci. 2006;63(19\u201320):2317\u201328. https:\/\/doi.org\/10.1007\/s00018-006-6095-6. PubMed PMID: 16909212; PubMed Central PMCID: PMCPMC11136376.","journal-title":"Cell Mol Life Sci"},{"key":"356_CR23","doi-asserted-by":"publisher","unstructured":"Horisawa K, Udono M, Ueno K, Ohkawa Y, Nagasaki M, Sekiya S et al. The Dynamics of Transcriptional Activation by Hepatic Reprogramming Factors. Mol Cell. 2020;79(4):660\u2009\u2013\u200976.e8. https:\/\/doi.org\/10.1016\/j.molcel.2020.07.012.\u00a0. Epub 20200804. PubMed PMID: 32755593.","DOI":"10.1016\/j.molcel.2020.07.012"},{"key":"356_CR24","doi-asserted-by":"publisher","unstructured":"Warren I, Moeller MM, Guiggey D, Chiang A, Maloy M, Ogoke O et al. FOXA1\/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell-derived hepatic progenitor cells. FASEB J. 2023;37(1):e22652. https:\/\/doi.org\/10.1096\/fj.202101506RRR. PubMed PMID: 36515690.","DOI":"10.1096\/fj.202101506RRR"},{"key":"356_CR25","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.2147\/ott.S252890","volume":"13","author":"Z Yuan","year":"2020","unstructured":"Yuan Z, Ye M, Qie J, Ye T. FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p\/FOXA1\/AGR2 Signaling Pathway. Onco Targets Ther. 2020;13:5231\u201340. https:\/\/doi.org\/10.2147\/ott.S252890. Epub 20200609.","journal-title":"Onco Targets Ther"},{"key":"356_CR26","doi-asserted-by":"publisher","unstructured":"van den Boomen DJ, Timms RT, Grice GL, Stagg HR, Sk\u00f8dt K, Dougan G, et al. TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I. Proceedings of the National Academy of Sciences of the United States of America. Proc Natl Acad Sci USA. 2014;111(31):11425\u201330. https:\/\/doi.org\/10.1073\/pnas.1409099111. Epub 20140716. PubMed PMID: 25030448; PubMed Central PMCID: PMCPMC4128144.","DOI":"10.1073\/pnas.1409099111"},{"issue":"1","key":"356_CR27","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1038\/s41467-024-53639-x","volume":"15","author":"Z Song","year":"2024","unstructured":"Song Z, Thepsuwan P, Hur WS, Torres M, Wu SA, Wei X, et al. Regulation of hepatic inclusions and fibrinogen biogenesis by SEL1L-HRD1 ERAD. Nat Commun. 2024;15(1):9244. https:\/\/doi.org\/10.1038\/s41467-024-53639-x. Epub 20241026.","journal-title":"Nat Commun"},{"issue":"49","key":"356_CR28","doi-asserted-by":"publisher","first-page":"16743","DOI":"10.1074\/jbc.RA120.013987","volume":"295","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yang X, Long G, Hu Y, Gu Z, Boisclair YR, et al. ERAD deficiency promotes mitochondrial dysfunction and transcriptional rewiring in human hepatic cells. J Biol Chem. 2020;295(49):16743\u201353. https:\/\/doi.org\/10.1074\/jbc.RA120.013987. Epub 20200925.","journal-title":"J Biol Chem"},{"key":"356_CR29","doi-asserted-by":"publisher","first-page":"116110","DOI":"10.1016\/j.taap.2022.116110","volume":"449","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang Y, Li Y, Jiang S, Xu F, Li K, et al. Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022;449:116110. https:\/\/doi.org\/10.1016\/j.taap.2022.116110. Epub 2022\/06\/11.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"356_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/0008-5472.Can-11-0943","volume":"72","author":"S Shah","year":"2012","unstructured":"Shah S, Prasad S, Knudsen KE. Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. Cancer Res. 2012;72(5):1248\u201359. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-0943. Epub 2012\/01\/20.","journal-title":"Cancer Res"},{"issue":"5","key":"356_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/mutage\/ger021","volume":"26","author":"C Magkoufopoulou","year":"2011","unstructured":"Magkoufopoulou C, Claessen SM, Jennen DG, Kleinjans JC, van Delft JH. Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011;26(5):593\u2013604. https:\/\/doi.org\/10.1093\/mutage\/ger021. Epub 2011\/06\/03.","journal-title":"Mutagenesis"},{"issue":"27","key":"356_CR32","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1074\/jbc.M702452200","volume":"282","author":"JL Su","year":"2007","unstructured":"Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem. 2007;282(27):19385\u201398. https:\/\/doi.org\/10.1074\/jbc.M702452200. Epub 2007\/05\/22.","journal-title":"J Biol Chem"},{"issue":"12","key":"356_CR33","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1021\/pr500714a","volume":"13","author":"A Alayev","year":"2014","unstructured":"Alayev A, Doubleday PF, Berger SM, Ballif BA, Holz MK. Phosphoproteomics reveals resveratrol-dependent inhibition of Akt\/mTORC1\/S6K1 signaling. J Proteome Res. 2014;13(12):5734\u201342. https:\/\/doi.org\/10.1021\/pr500714a. Epub 2014\/10\/15.","journal-title":"J Proteome Res"},{"key":"356_CR34","doi-asserted-by":"publisher","unstructured":"Zhang E, Yin S, Song X, Fan L, Hu H. Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress\/GSK-3-mediated mitochondrial pathway. Sci Rep. 2016;6:38138. https:\/\/doi.org\/10.1038\/srep38138.\u00a0 Epub 2016\/12\/03.","DOI":"10.1038\/srep38138"},{"key":"356_CR35","doi-asserted-by":"publisher","first-page":"115858","DOI":"10.1016\/j.taap.2021.115858","volume":"436","author":"Z Wu","year":"2022","unstructured":"Wu Z, Geng Y, Buist-Homan M, Moshage H. Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress. Toxicol Appl Pharmacol. 2022;436:115858. https:\/\/doi.org\/10.1016\/j.taap.2021.115858. Epub 2022\/01\/04.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"356_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12550-025-00586-1","volume":"41","author":"Q Su","year":"2025","unstructured":"Su Q, Pan H, Hong P, You Y, Wu Y, Zou J, et al. Protective effect of curcumin against endoplasmic reticulum stress and lipid metabolism disorders in AFB1-intoxicated duck liver. Mycotoxin Res. 2025;41(2):359\u201372. https:\/\/doi.org\/10.1007\/s12550-025-00586-1. Epub 2025\/03\/14.","journal-title":"Mycotoxin Res"},{"key":"356_CR37","doi-asserted-by":"publisher","unstructured":"Lee DE, Lee SJ, Kim SJ, Lee HS, Kwon OS. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation. Nutrients. 2019;11(11). https:\/\/doi.org\/10.3390\/nu11112702. PubMed PMID: 31717261; PubMed Central PMCID: PMCPMC6893521. Epub 2019\/11\/14.","DOI":"10.3390\/nu11112702"},{"key":"356_CR38","doi-asserted-by":"publisher","unstructured":"Gnoni A, Di Chiara Stanca B, Giannotti L, Gnoni GV, Siculella L, Damiano F. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1\/AMPK\/PP2A Axis. Int J Mol Sci. 2022;23(3). https:\/\/doi.org\/10.3390\/ijms23031044. PubMed PMID: 35162967; PubMed Central PMCID: PMCPMC8834998. Epub 2022\/02\/16.","DOI":"10.3390\/ijms23031044"},{"issue":"14","key":"356_CR39","doi-asserted-by":"publisher","first-page":"e2000105","DOI":"10.1002\/mnfr.202000105","volume":"64","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhang H, Chen Y, Zhang Y, Shen M, Jia P, et al. Resveratrol Alleviates Endoplasmic Reticulum Stress-Associated Hepatic Steatosis and Injury in Mice Challenged with Tunicamycin. Mol Nutr Food Res. 2020;64(14):e2000105. https:\/\/doi.org\/10.1002\/mnfr.202000105. Epub 2020\/06\/13.","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"356_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.nutres.2015.05.006","volume":"35","author":"QR Pan","year":"2015","unstructured":"Pan QR, Ren YL, Liu WX, Hu YJ, Zheng JS, Xu Y, et al. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats. Nutr Res. 2015;35(7):576\u201384. https:\/\/doi.org\/10.1016\/j.nutres.2015.05.006. Epub 2015\/06\/10.","journal-title":"Nutr Res"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-026-00356-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00356-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:02:39Z","timestamp":1792162959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-026-00356-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/s12575-026-00356-y","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental protocols were approved by the Medical Ethics Committee of the Zhenjiang Hospital of Traditional Chinese Medicine (Approval Number: 2024002), and the animal procedures adhered to the ARRIVE guidelines 2.0.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}